Current Signal Transduction Therapy

Editor-in-Chief:

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
USA

Back

Become EABM
Become Reviewer

Targeting Neurotrophic Signal Transduction Pathways in the Treatment of Mood Disorders

Volume:2   Issue: 2
Pp: 101-110
Todd D. Gould and Husseini K. Manji
DOI: 10.2174/157436207780619518

Smad-Signaling in Mammary Gland Development and Tumorigenesis

Volume:2   Issue: 2
Pp: 111-120
Vandana Gupta, Arunthathi Thiagalingam and Shyamala Maheswaran
DOI: 10.2174/157436207780619482

Nitric Oxide: Friendly Rivalry in Tuberculosis

Volume:2   Issue: 2
Pp: 121-128
Sangita Mukhopadhyay, Shiny Nair and Seyed E. Hasnain
DOI: 10.2174/157436207780619536

Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors

Volume:2   Issue: 2
Pp: 129-143
Matthew E. Peters, Mohammed M. Shareef, Seema Gupta, Marianna Zagurovskaya-Sultanov, Munira Kadhim, Mohammed Mohiuddin and Mansoor M. Ahmed
DOI: 10.2174/157436207780619509

Oncogene-Directed Therapies as Modulators of Cancer Coagulopathy, Angiogenesis and Tumor-Vascular Interface

Volume:2   Issue: 2
Pp: 157-163
Janusz Rak, Chloe Milsom, Linda May and Joanne Yu
DOI: 10.2174/157436207780619473

Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours

Volume:2   Issue: 2
Pp: 165-173
P. Tagliaferri, P. Tassone, A. Pietragalla, M. S. Rotundo, V. Barbieri, A. Budillon, M. Caraglia, F. S. Costanzo and S. Venuta
DOI: 10.2174/157436207780619491

Blocking Apoptotic Intracellular Signaling Cascades with Cell-Permeable Peptides

Volume:2   Issue: 2
Pp: 175-179
Azel Zine, Alain Uziel, Jacques Beckmann and Christophe Bonny
DOI: 10.2174/157436207780619527